Biolinq develops precision multi-analyte wearable sensors, including a glucose sensor patch, to improve metabolic health by providing real-time feedback to users.

Glycomine is a biotechnology company developing therapies for rare diseases, specifically targeting PMM2-CDG with its investigational drug GLM101.

Alleviant Medical, Inc. develops minimally invasive medical devices for treating heart failure, specifically through a no-implant atrial shunt.

InterVene is a medical device company developing the Recana catheter system to treat chronic venous insufficiency and deep venous obstruction.

Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.